INBX peer analysis
Inhibrx Biosciences (INBX) against its competitors: price, today's move, 1-year return and market value side by side.
INBX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABSI Absci | $10.06 | 7.14% | 140.86% | – |
| CLDX Celldex Therapeutics | $30.00 | 6.12% | 18.41% | $2.35B |
| GENB Generate Biomedicines | $13.06 | 3.90% | – | – |
| IMTX Immatics | $6.36 | 2.91% | -33.35% | – |
| JANX Janux | $17.63 | 9.78% | -40.61% | – |
| TECX Tectonic Therapeutic | $22.34 | 15.04% | 15.71% | – |
| INBX Inhibrx Biosciences | $82.41 | 2.65% | -2.31% | – |
- INBX's peers: ABSI (Absci), CLDX (Celldex Therapeutics), GENB (Generate Biomedicines), IMTX (Immatics), JANX (Janux), TECX (Tectonic Therapeutic).
Updated 2026-11-07 11:56 UTC